Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerzy Jankun

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Pneumonologia I Alergologia Polska|July 29, 2010
[Cell phenotype determines PAI-1 antiproliferative effect - suppressed proliferation of the lung cancer but not prostate cancer cells]Joanna Chorostowska-Wynimko, Marta Kedzior, Radosław Struniawski, et al.
International Journal of Molecular Sciences|January 19, 2018
Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?Marzena Wyganowska-Świątkowska, Maja Matthews-Kozanecka, Teresa Matthews-Brzozowska, et al.
BJU International|November 17, 2009
Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse modelJerzy Jankun, Steven H Selman, Rick W Keck, et al.
Molecular Cancer Therapeutics|January 21, 2003
A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesisJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
International Journal of Molecular Medicine|September 28, 2011
Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structureJerzy Jankun, Jie Yang, Hong Zheng, et al.
International Journal of Oncology|December 9, 2004
In vivo and in vitro effect of baicalein on human prostate cancer cellsRanko Miocinovic, N Patrick McCabe, Rick W Keck, et al.
Pharmacological Reports : PR|October 10, 2009
Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-lifeJerzy Jankun, Ansari M Aleem, Radosław Struniawski, et al.
International Journal of Molecular Medicine|November 4, 2009
Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behaviorAnsari M Aleem, Leigh Wells, Jerzy Jankun, et al.
Oncology Reports|July 25, 2012
Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancerAmira Gohara, Noha Eltaki, Dina Sabry, et al.
Oncology Reports|May 8, 2012
L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytesJarosław Szefel, Wiesław Janusz Kruszewski, Maciej Ciesielski, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pneumonologia I Alergologia Polska|July 29, 2010
[Cell phenotype determines PAI-1 antiproliferative effect - suppressed proliferation of the lung cancer but not prostate cancer cells]Joanna Chorostowska-Wynimko, Marta Kedzior, Radosław Struniawski, et al.
International Journal of Molecular Sciences|January 19, 2018
Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?Marzena Wyganowska-Świątkowska, Maja Matthews-Kozanecka, Teresa Matthews-Brzozowska, et al.
BJU International|November 17, 2009
Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse modelJerzy Jankun, Steven H Selman, Rick W Keck, et al.
Molecular Cancer Therapeutics|January 21, 2003
A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesisJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
International Journal of Molecular Medicine|September 28, 2011
Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structureJerzy Jankun, Jie Yang, Hong Zheng, et al.
International Journal of Oncology|December 9, 2004
In vivo and in vitro effect of baicalein on human prostate cancer cellsRanko Miocinovic, N Patrick McCabe, Rick W Keck, et al.
Pharmacological Reports : PR|October 10, 2009
Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-lifeJerzy Jankun, Ansari M Aleem, Radosław Struniawski, et al.
International Journal of Molecular Medicine|November 4, 2009
Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behaviorAnsari M Aleem, Leigh Wells, Jerzy Jankun, et al.
Oncology Reports|July 25, 2012
Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancerAmira Gohara, Noha Eltaki, Dina Sabry, et al.
Oncology Reports|May 8, 2012
L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytesJarosław Szefel, Wiesław Janusz Kruszewski, Maciej Ciesielski, et al.
Pageof 7